Growth Opportunities in the Oral Solid Dosage Formulation Industry

Growth Opportunities in the Oral Solid Dosage Formulation Industry

Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential

RELEASE DATE
09-Apr-2024
REGION
North America
Deliverable Type
Market Research
Research Code: PFI7-01-00-00-00
SKU: HC_2024_658
AvailableYesPDF Download
$2,450.00
In stock
SKU
HC_2024_658
$2,450.00
DownloadLink
ENQUIRE NOW

Description

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry’s growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.


Research Highlights:

  • Impact of strategic imperatives on the industry 
  • Growth drivers and restraints 
  • Oral solid dosage based on API release profile
  • R&D pipeline and product innovations
  • Small molecule oral dosage market overview
  • Small molecule oral solid dosage formulation by therapy area
  • Innovations in extended-release dosage forms
  • Industry trends and emerging technologies
  • Supply chain resilience strategies – focus areas
  • Investment trends – Expansion and capability-building initiatives
  • Consolidation trends – mergers & acquisitions
  • company benchmarking
  • oral drug delivery solutions & services
  • Growth opportunities

Author: Supriya Lala Kundu

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Oral Solid Dosage Formulation Industry

Scope of Analysis

Industry Definition and Segmentation

Definition—OSD Based on API Release Profile

Growth Drivers

Growth Restraints

R&D Pipeline and Product Innovations

Small Molecule Oral Dosage Formulation Industry Overview

Small Molecule Oral Dosage Formulation Industry Overview (continued)

Small Molecule OSD Formulation by Therapy Area

Small Molecule OSD Formulation Therapy Area by Dosage Form

Innovations in Extended Release Dosage forms

Industry Trends and Emerging Technologies

Industry Trends and Emerging Technologies (continued)

Industry Trends and Emerging Technologies (continued)

Industry Trends and Emerging Technologies (continued)

Industry Trends and Emerging Technologies (continued)

Industry Trends and Emerging Technologies (continued)

Industry Trends and Emerging Technologies (continued)

Regional Policies and Initiatives

Regional Policies and Initiatives (continued)

Regional Policies and Initiatives (continued)

Regional Policies and Initiatives (continued)

OSD Manufacturing—Production Flow

OSD Manufacturing—Production Flow (continued)

Vendor Ecosystem

Small Molecule OSD CDMO Industry Revenue

OSD CDMO Industry Overview

Supply Chain Resilience Strategies—Focus Areas

Investment Trends—Expansion and Capability Building

Investment Trends—Expansion and Capability Building (continued)

Consolidation Trends—Mergers & Acquisitions

Growth Themes and Business Models

Company Benchmarking—Oral Drug Delivery Solutions and Services

Company Benchmarking Analysis

Company Benchmarking Analysis (continued)

Companies to Watch

Companies to Watch (continued)

Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases

Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases (continued)

Growth Opportunity 2: Medical Cannabidiol

Growth Opportunity 2: Medical Cannabidiol (continued)

Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs

Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs (continued)

Growth Opportunity 4: Additive Manufacturing for Personalized Medicine

Growth Opportunity 4: Additive Manufacturing for Personalized Medicine (continued)

Best Practices Recognition

Frost Radar

Benefits and Impacts of Growth Opportunities

Next Steps

Take the Next Step

List of Exhibits

Legal Disclaimer

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry s growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.--BEGIN PROMO--

Research Highlights:

  • Impact of strategic imperatives on the industry 
  • Growth drivers and restraints 
  • Oral solid dosage based on API release profile
  • R&D pipeline and product innovations
  • Small molecule oral dosage market overview
  • Small molecule oral solid dosage formulation by therapy area
  • Innovations in extended-release dosage forms
  • Industry trends and emerging technologies
  • Supply chain resilience strategies – focus areas
  • Investment trends – Expansion and capability-building initiatives
  • Consolidation trends – mergers & acquisitions
  • company benchmarking
  • oral drug delivery solutions & services
  • Growth opportunities

Author: Supriya Lala Kundu

More Information
Deliverable Type Market Research
Author Supriya Lala Kundu
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number PFI7-01-00-00-00